Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  PAREXEL International Corporation    PRXL

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo PAREXEL International Corp
Provides clinical research and development services

PAREXEL International Corp. engages in the provision of biopharmaceutical outsourcing services.

It operates through the following segments: Clinical Research Services, PAREXEL Consulting, and PAREXEL Informatics.

The Clinical Research Services segment includes clinical trials management and biostatistics, data management and clinical pharmacology, as well as related medical advisory, patient recruitment, clinical supply and drug logistics, pharmacoviligance, and investigator site services.

The PAREXEL Consulting segment focuses on technical expertise and advice in such areas as drug development, regulatory affairs, product pricing and reimbursement, commercialization, and strategic compliance.

The PAREXEL Informatics segment offers information technology solutions designed to help improve client's product development, and regulatory submission processes.

The company was founded by Josef H. von Rickenbach and Anne B. Sayigh in 1983 and is headquartered in Waltham, MA.
Managers
NameAgeSinceTitle
Josef H. von Rickenbach, MBA621983Chief Executive Officer & Director
Mark A. Goldberg, MD571997President & Chief Operating Officer
Simon John Harford, MBA562017Chief Financial Officer & Senior Vice President
Sy Pretorius MD, MBA472010Chief Scientific Officer & Senior Vice President
Jeremy Gelber-2017Director
Mark Stephenson--VP-Corporate Communications
Douglas Alexander Batt572006Secretary, Senior Vice President & General Counsel
Gadi Saarony492003Senior Vice President-Clinical Research Services
Roland Andersson, PhD532014Senior Vice President-Clinical Research Services
David J. Godwin, MBA--Senior Vice President-Global Business Development
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 51,115,310 50,131,867 98.1% 0 0.0% 98.1%
Company contact information
PAREXEL International Corp.
195 West Street
Waltham, MA 02451

Phone : +1.781.487.9900
Fax : +1.781.487.0525
Web : www.parexel.com
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
PAREXEL INTERNATIONAL CORPORATION34.02%0
CELLTRION, INC.--.--%22 034
IQVIA HOLDINGS INC32.81%21 333
INCYTE CORPORATION-6.46%20 382
LONZA GROUP54.74%19 270
ALNYLAM PHARMACEUTICALS, INC.239.21%12 871
SEATTLE GENETICS, INC.7.54%8 529
NEKTAR THERAPEUTICS323.15%8 499
ALKERMES PLC-5.04%8 132
QIAGEN NV6.61%7 250
SAGE THERAPEUTICS INC75.85%6 870
IONIS PHARMACEUTICALS INC12.75%6 790
EXACT SCIENCES CORPORATION300.45%6 445
ICON PLC49.61%6 048
UNITED THERAPEUTICS CORPORATION-6.46%5 886
PRA HEALTH SCIENCES INC46.95%5 241
CHARLES RIVER LABORATORIES INTL. INC33.64%4 918
BIO-TECHNE CORP24.93%4 824
GALAPAGOS19.28%4 402
INC RESEARCH HOLDINGS INC-27.85%4 127
FIBROGEN INC107.71%3 805
Connections : PAREXEL International Corp
New England Healthcare Institute
Pamplona Capital Management LLP
Harvard T.H. Chan School of Public Health
Boston Millennia Partners
PAREXEL Informatics, Inc.
© 2017 People , Fundamentals and Ownership